Pembrolizumab plus enfortumab vedotin-ejfv improved event free survival in patients with muscle invasive bladder cancer who decline or are ineligible for cisplatin-based chemotherapy.

The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.

Ianalumab added to eltrombopag significantly prolonged the time to treatment failure in adults with primary immune thrombocytopenia.

The FDA has removed the recommended pause in the use of Valneva’s chikungunya vaccine Ixchiq in individuals aged 60 years and older.

The FDA has approved new safety labeling changes for Skysona (elivaldogene autotemcel) due to the increased risk of hematologic malignancy.

The FDA has approved Brinsupri (brensocatib) for the treatment of non-cystic fibrosis bronchiectasis in adult and pediatric patients aged 12 years and older.

The Food and Drug Administration has approved the first generic version of Venofer (iron sucrose) Injection.

The accelerated approval was based on the single-arm, open-label, phase 1b Beamion LUNG-1 trial.

Kerendia (finerenone) Nonsteroidal mineralocorticoid receptor antagonist. To reduce the risk of cardiovascular death, hospitalization for heart failure (HF), and urgent HF visits in adult patients ...

Findings showed both trials met the primary endpoint, demonstrating statistically significant improvement in Sjögren disease activity vs placebo.

DermaRite is instructing distributors and customers to examine their inventory and destroy all affected products. DermaRite Industries, LLC is recalling multiple products, including antiseptic ...

During the 10 years of follow-up the risk for dementia was lower across each BMI group. HealthDay News — Metformin use is associated with lower risks for dementia and all-cause mortality across ...